Reuters logo
BRIEF-4SC says first patient enrolled in pivotal RESMAIN study of resminostat in CTCL
December 16, 2016 / 6:33 AM / a year ago

BRIEF-4SC says first patient enrolled in pivotal RESMAIN study of resminostat in CTCL

Dec 16 (Reuters) - 4SC AG :

* First patient enrolled in pivotal RESMAIN study of resminostat in CTCL

* Topline data expected in 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below